(Q44529922)

3 December 2017

Spontaneous bacterial peritonitis: prevention and therapy (English)

1 reference

Spontaneous bacterial peritonitis

3 December 2017

1 reference

Hoefs JC

1

1 reference

PubMed ID

2210680

3 December 2017

language of work or name

English

0 references

publication date

1 October 1990

1 reference

3 December 2017

1 reference

3 December 2017

12

1 reference

3 December 2017

4 Pt 1

1 reference

3 December 2017

776-781

1 reference

Ascitic fluid polymorphonuclear cell count and serum to ascites albumin gradient in the diagnosis of bacterial peritonitis.

3 December 2017

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

Antibiotic penetrance of ascitic fluid in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

Prophylactic trimethoprim-sulfamethoxazole during consolidation chemotherapy for acute leukemia: a controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

Antibiotic prophylaxis in acute leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

Bacteriological aspects of selective decontamination of the digestive tract as a method of infection prevention in granulocytopenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

Selective antimicrobial modulation of human microbial flora: infection prevention in patients with decreased host defense mechanisms by selective elimination of potentially pathogenic bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

Neomycin absorption in man. Studies of oral and enema administration and effect of intestinal ulceration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

Norfloxacin: a new targeted fluoroquinolone antimicrobial agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

In vitro antibacterial activity of norfloxacin (MK-0366).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

Selective antimicrobial modulation of the intestinal tract by norfloxacin in human volunteers and in gnotobiotic mice associated with a human fecal flora

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

Penetration of cefoperazone into ascites

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

Spontaneous bacterial peritonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

Reticuloendothelial System Phagocytic Activity in Cirrhosis and Its Relation to Bacterial Infections and Prognosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

Problems of bacterial infection in patients with liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

A prospective evaluation of bacteremic patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

Diagnostic paracentesis. A potent clinical tool

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

Spontaneous bacterial peritonitis: an explosion of information

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

NORMAL BACTERIAL POPULATIONS OF THE INTESTINE AND THEIR RELATION TO INTESTINAL FUNCTION

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

The normal microbial flora

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

pH of ascitic fluid: diagnostic and prognostic value in cirrhotic and noncirrhotic patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

Spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

Spontaneous bacterial empyema in cirrhotic patients: analysis of eleven cases

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

Effects of lactulose and Lactobacillus acidophilus on the fecal flora

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

Effect of paromomycin on the bacterial flora of the human intestine: studies of total numbers and specific components

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

The dose at which neomycin and polymyxin B can be applied for selective decontamination of the digestive tract in mice

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

Partial antibiotic decontamination

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

The serum concentration of the third component of complement 1C/ 1A in liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

Complement and liver cell function in 53 patients with liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

Abnormalities of neutrophil phagocytosis, intracellular killing and metabolic activity in alcoholic cirrhosis and hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

Role of serum complement, immunoglobulins, and cell-mediated immune system in the pathogenesis of spontaneous bacterial peritonitis (SBP).

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

Bacteriuria and primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

Opsonic activity of human ascitic fluid: a potentially important protective mechanism against spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

Patients with deficient ascitic fluid opsonic activity are predisposed to spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

Low C3 in cirrhotic ascites predisposes to spontaneous bacterial peritonitis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

Increase in ascites white blood cell and protein concentrations during diuresis in patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

THE EFFECTS OF INTRAVENOUS INJECTION OF CONCENTRATED HUMAN SERUM ALBUMIN UPON BLOOD PLASMA, ASCITES AND RENAL FUNCTIONS IN THREE PATIENTS WITH CIRRHOSIS OF THE LIVER.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

Effect of diuresis versus therapeutic paracentesis on ascitic fluid opsonic activity and serum complement

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

Antibiotic concentrations in ascitic fluid of patients with ascites and bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

Infections in cancer patients on a protected environment-prophylactic antibiotic program

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

Protected environments and prophylactic antibiotics. A prospective controlled study of their utility in the therapy of acute leukemia

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

Infection by and distribution of biotypes of Enterobacteriaceae species in leukaemic patients treated under ward conditions and in units for protective isolation in seven hospitals in Europe

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

Colonization resistance of the digestive tract: clinical consequences and implications.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

Failure of oral trimethoprim-sulfamethoxazole prophylaxis in acute leukemia: isolation of resistant plasmids from strains of Enterobacteriaceae causing bacteremia

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

Trimethoprim/sulfamethoxazole prophylaxis in neutropenic patients. Reduction of infections and effect on bacterial and fungal flora.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

Double-blind randomized study of prophylactic trimethoprim/sulfamethoxazole in granulocytopenic patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

Superinfection: another look

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

A comparison of trimethoprim-sulfamethoxazole plus nystatin with gentamicin plus nystatin in the prevention of infections in acute leukemia

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

A prospective controlled investigation of prophylactic trimethoprim/sulfamethoxazole in hospitalized granulocytopenic patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

Infectious Drug Resistance in Enteric Bacteria

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

Effect of norfloxacin on human oropharyngeal and colonic microflora and multiple-dose pharmacokinetics

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

Evaluation of aztreonam in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

Cefotaxime concentrations in ascites

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

Protein binding of ceftriaxone in extravascular fluids

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

Oral pharmacokinetics and ascitic fluid penetration of pefloxacin in cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

Oral pharmacokinetics and ascitic fluid penetration of ofloxacin in cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

Use of ceftriaxone in the treatment of bacterial infections in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

Polymorphonuclear cell count response and duration of antibiotic therapy in spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120424

7 January 2021

Identifiers

DOI

10.1002/HEP.1840120424

1 reference

3 December 2017

1 reference

PubMed ID

2210680